| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |